Company intelligence / Profile preview

Integrated Nonclinical Development Solutions

Ann Arbor, Michigan, United States

Ownership: Private
Development stage: Other

Overview

Integrated Nonclinical Development Solutions (INDS) was a Contract Research Organization (CRO) and software provider that offered nonclinical drug development services, including program design, safety analysis, and regulatory submission support, leveraging its SEND Explorer® software for data visualization. INDS was acquired by Certara in 2022.

Industry: Contract Research Organization

Beyond the preview

Go deeper on Integrated Nonclinical Development Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integrated Nonclinical Development Solutions.

Explore the full profile